-
Je něco špatně v tomto záznamu ?
Synthesis and in vitro evaluation of new derivatives of 2-substituted-6-fluorobenzo[d]thiazoles as cholinesterase inhibitors
A. Imramovský, V. Pejchal, Š. Štěpánková, K. Vorčáková, J. Jampílek, J. Vančo, P. Šimůnek, K. Královec, L. Brůčková, J. Mandíková, F. Trejtnar,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- acetylcholinesterasa metabolismus MeSH
- buňky Hep G2 MeSH
- butyrylcholinesterasa metabolismus MeSH
- cholinesterasové inhibitory chemická syntéza chemie farmakologie toxicita MeSH
- halogenace MeSH
- karbamáty chemická syntéza chemie farmakologie toxicita MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- simulace molekulového dockingu MeSH
- thiazoly chemická syntéza chemie farmakologie toxicita MeSH
- viabilita buněk účinky léků MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A series of novel cholinesterase inhibitors based on 2-substituted 6-fluorobenzo[d]thiazole were synthesised and characterised by IR, (1)H, (13)C and (19)F NMR spectroscopy and HRMS. Purity was checked by elemental analyses. The novel carbamates were tested for their ability to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The toxicity of the most active compounds was investigated using a standard in vitro test with HepG2 cells, and the ratio between biological activity and toxicity was determined. In addition, the toxicity of the most active compounds was evaluated against MCF7 cells using the xCELLigence system. Structure-activity relationships reflecting the dependence of cholinesterase inhibitors on the lipophilicity of the compounds as well as on the Taft polar and steric substituent constants are discussed. The specific orientation of the inhibitors in the binding site of acetylcholinesterase was determined using molecular docking of the most active compound.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13031565
- 003
- CZ-PrNML
- 005
- 20131003101904.0
- 007
- ta
- 008
- 131002s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bmc.2013.01.052 $2 doi
- 035 __
- $a (PubMed)23462716
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Imramovský, Aleš $u Institute of Organic Chemistry and Technology, Faculty of Chemical Technology, University of Pardubice, Studentská 573, CZ-532 10 Pardubice, Czech Republic. Ales.Imramovsky@upce.cz
- 245 10
- $a Synthesis and in vitro evaluation of new derivatives of 2-substituted-6-fluorobenzo[d]thiazoles as cholinesterase inhibitors / $c A. Imramovský, V. Pejchal, Š. Štěpánková, K. Vorčáková, J. Jampílek, J. Vančo, P. Šimůnek, K. Královec, L. Brůčková, J. Mandíková, F. Trejtnar,
- 520 9_
- $a A series of novel cholinesterase inhibitors based on 2-substituted 6-fluorobenzo[d]thiazole were synthesised and characterised by IR, (1)H, (13)C and (19)F NMR spectroscopy and HRMS. Purity was checked by elemental analyses. The novel carbamates were tested for their ability to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The toxicity of the most active compounds was investigated using a standard in vitro test with HepG2 cells, and the ratio between biological activity and toxicity was determined. In addition, the toxicity of the most active compounds was evaluated against MCF7 cells using the xCELLigence system. Structure-activity relationships reflecting the dependence of cholinesterase inhibitors on the lipophilicity of the compounds as well as on the Taft polar and steric substituent constants are discussed. The specific orientation of the inhibitors in the binding site of acetylcholinesterase was determined using molecular docking of the most active compound.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a butyrylcholinesterasa $x metabolismus $7 D002091
- 650 _2
- $a karbamáty $x chemická syntéza $x chemie $x farmakologie $x toxicita $7 D002219
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a cholinesterasové inhibitory $x chemická syntéza $x chemie $x farmakologie $x toxicita $7 D002800
- 650 _2
- $a halogenace $7 D054879
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a thiazoly $x chemická syntéza $x chemie $x farmakologie $x toxicita $7 D013844
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pejchal, Vladimír $u -
- 700 1_
- $a Štěpánková, Šárka $u -
- 700 1_
- $a Vorčáková, Katarína $u -
- 700 1_
- $a Jampílek, Josef $u -
- 700 1_
- $a Vančo, Ján $u -
- 700 1_
- $a Šimůnek, Petr $u -
- 700 1_
- $a Královec, Karel $u -
- 700 1_
- $a Brůčková, Lenka $u -
- 700 1_
- $a Mandíková, Jana $u -
- 700 1_
- $a Trejtnar, František $u -
- 773 0_
- $w MED00000769 $t Bioorganic & medicinal chemistry $x 1464-3391 $g Roč. 21, č. 7 (2013), s. 1735-48
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23462716 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20131002 $b ABA008
- 991 __
- $a 20131003102422 $b ABA008
- 999 __
- $a ok $b bmc $g 995652 $s 830010
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 21 $c 7 $d 1735-48 $i 1464-3391 $m Bioorganic & medicinal chemistry $n Bioorg Med Chem $x MED00000769
- LZP __
- $a Pubmed-20131002